3-n-methylspiperone has been researched along with carfentanil in 2 studies
Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (carfentanil) | Trials (carfentanil) | Recent Studies (post-2010) (carfentanil) |
---|---|---|---|---|---|
155 | 6 | 7 | 271 | 27 | 136 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wagner, HN | 1 |
Dannals, RF; Kao, PF; Kim, S; Lever, JR; Ravert, HT; Wagner, HN | 1 |
2 other study(ies) available for 3-n-methylspiperone and carfentanil
Article | Year |
---|---|
Radiolabeled drugs as probes of central nervous system neurons.
Topics: Adult; Aged; Aging; Brain; Brain Chemistry; Female; Fentanyl; Forecasting; Humans; Isotope Labeling; Male; Middle Aged; Neurons; Receptors, Dopamine; Receptors, Opioid; Receptors, Opioid, mu; Spiperone; Synaptic Transmission; Tomography, Emission-Computed | 1985 |
Assessing neuroreceptor occupancy by continuous infusion of carbon-11 labeled radioligands.
Topics: Adult; Brain; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Fentanyl; Humans; Infusion Pumps; Male; Raclopride; Radioligand Assay; Radionuclide Imaging; Receptors, Opioid; Salicylamides; Spiperone | 1996 |